Exploring the antitumor potential of novel quinoline derivatives <i>via</i> tubulin polymerization inhibition in breast cancer; design, synthesis and molecular docking-Reference-Cited by-同舟云学术

Exploring the antitumor potential of novel quinoline derivatives via tubulin polymerization inhibition in breast cancer; design, synthesis and molecular docking

Published:2024 Issue:31 Volume:14 Page:22092-22112
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Abdelmegeed Heba¹,Abdel Ghany Lina M. A.²^ORCID,Youssef Amira³,El-Etrawy Abd-Allah S.³⁴,Ryad Noha³

Affiliation:

1. Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Giza 12622, Egypt

2. Pharmaceutical Chemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), 6th of October City, P.O. Box 77, Giza, Egypt

3. Pharmaceutical Organic Chemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), 6th of October City, P.O. Box 77, Giza, Egypt

4. Department of Chemistry, Basic Science, Misr University for Science and Technology (MUST), 6th of October City, P.O. Box 77, Giza, Egypt

Abstract

A series of quinoline derivatives was designed and synthesized as novel tubulin inhibitors targeting the colchicine binding site.

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/RA/D4RA04371E

Reference59 articles.

1. Role of Plant derived-medicine for controlling Cancer

2. Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review

3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

4. Targeting Microtubules by Natural Agents for Cancer Therapy